Last reviewed · How we verify
Alcohol Treatment: Pragmatic Therapeutic Trial Randomized, Double-blind for a Year in Ambulatory Care of Baclofen Versus Placebo. (BACLOVILLE)
The main objective of this study is to show the effectiveness to a year of baclofen compared to placebo, on the proportion of patients with a low risk alcohol consumption or no, according to the WHO standards.
Details
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Phase | Phase 2/Phase 3 |
| Status | COMPLETED |
| Enrolment | 323 |
| Start date | 2012-05-29 |
| Completion | 2015-10 |
Conditions
- Alcoholism
Interventions
- Baclofen
- Placebo
Primary outcomes
- Proportion of abstainer patients and patients with a low risk consumption — 12 months after the initiation of treatment
Low risk consumption according to the criteria of WHO (World Health Organization). The assessment will be on the declarative of the patient (with autoquestionnaire). It will be compared between the two groups using a Chi-2 test.
Countries
France